Impact of population aging on trends in diabetes prevalence: A meta-regression analysis of 160,000 Japanese adults

Journal of Diabetes Investigation

Volumn 6, Issue 5, 2015, Pages 533-542

  Charvat, Hadrien ^a   Goto, Atsushi ^b   Goto, Maki ^b   Inoue, Machiko ^c   Heianza, Yoriko ^d   Arase, Yasuji ^e   Sone, Hirohito ^d   Nakagami, Tomoko ^f   Song, Xin ^g,h   Qiao, Qing ^g,h,i   Tuomilehto, Jaakko ^h,j,k   Tsugane, Shoichiro ^a   Noda, Mitsuhiko ^b   Inoue, Manami ^l  

^a NATIONAL CANCER CENTER   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e TORANOMON HOSPITAL   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g UNIVERSITY OF HELSINKI   (Finland)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ ASTRAZENECA R AND D   (Sweden)

^j DANUBE UNIVERSITY KREMS   (Austria)

^k KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^l UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Diabetes; Population aging; Prevalence

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; AGING; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; META REGRESSION ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX RATIO; TREND STUDY;

EID: 84940609041     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12333     Document Type: Article

References (62)

1. National Institute of Population and Social Security Research. Proportion of the population aged 65 or over: international comparison 2013; http://www.ipss.go.jp/syoushika/tohkei/Popular/P_Detail2013.asp?fname=T02-17.htm. Accessed January 14, 2014.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
3. Inoue M, Tsugane S. Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer 2012; 19: F1-F8.
4. Noto H, Tsujimoto T, Noda M. Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians. J Diabetes Invest 2012; 3: 24-33.
5. Vigneri P, Frasca F, Sciacca L, et al. Diabetes and cancer. Endocr Relat Cancer 2009; 16: 1103-1123.
6. IDF Diabetes Atlas Group. Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2011. Diabetes Res Clin Pract 2013; 100: 277-279.
7. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005; 67: 152-162.
8. Saito T, Watanabe M, Nishida J, et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med 2011; 171: 1352-1360.
9. Paulweber B, Valensi P, Lindstrom J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010; 42: S3-S36.
10. Yazaki Y, Kadowaki T. Combating diabetes and obesity in Japan. Nat Med 2006; 12: 73-74.
11. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378: 31-40.
12. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
13. Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-321.
14. Guariguata L, Linnenkamp U, Beagley J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy for 2013 for the IDF Diabetes Atlas. Diabetes Res Clin Pract 2014; 103: 176-185.
15. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-S69.
17. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. WHO, Abbreviated report of a WHO consultation, Geneva, 2011; 1-25.
18. Seino Y, Nanjo K, Tajima N, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010; 1: 212-228.
19. Cheng YJ, Imperatore G, Geiss LS, et al. Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010. Diabetes Care 2013; 36: 2690-2696.
20. Ministry of Health, Labour and Welfare. National Health and Nutrition Survey, 2011. 2011; http://www.mhlw.go.jp/bunya/kenkou/eiyou/h23-houkoku.html. Accessed 25 July, 2013.
21. Kashiwagi A, Kasuga M, Araki E, et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012; 3: 39-40.
22. Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004; 50: 166-174.
23. Goto A, Morita A, Goto M, et al. Validity of diabetes self-reports in the Saku Diabetes Study. J Epidemiol 2013; 23: 295-300.
24. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
25. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012.
26. Bando Y, Kanehara H, Aoki K, et al. Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: target populations for efficient screening. Diabetes Res Clin Pract 2009; 83: 341-346.
27. Kachi Y, Ohwaki K, Yano E. Association of sleep duration with untreated diabetes in Japanese men. Sleep Med 2012; 13: 307-309.
28. Yano Y, Sato Y, Fujimoto S, et al. Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sample. Diabetes Care 2012; 35: 1310-1315.
29. Miyashita M, Sawayama T, Hosaka S. et al [The evaluation of association between serum levels of gamma-glutamyl transferase and the prevalence rate of diabetes in occupational health checkup]. J Hiroshima Med Ass 2008; 61: 375-379.
30. Qiao Q, Hu G, Tuomilehto J, et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003; 26: 1770-1780.
31. Ohmura T, Ueda K, Kiyohara Y, et al. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama Study. Diabetologia 1993; 36: 1198-1203.
32. Sekikawa A, Tominaga M, Takahashi K, et al. Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care 1993; 16: 570-574.
33. Nagai M, Sakata K, Yanagawa H, et al. The prevalence of diabetes mellitus and impaired glucose tolerance studied by 75 gram oral glucose tolerance test in a rural island population. Jpn J Public Health 1992; 39: 907-912.
34. Takahashi Y, Noda M, Tsugane S, et al. Prevalence of diabetes estimated by plasma glucose criteria combined with standardized measurement of HbA1c among health checkup participants on Miyako Island, Japan. Diabetes Care 2000; 23: 1092-1096.
35. Noda M, Kato M, Takahashi Y, et al. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study - suggestion for the threshold for impaired fasting glucose among Japanese. Endocr J 2010; 57: 629-637.
36. Heianza Y, Hara S, Arase Y, et al. Impact of introducing HbA1c into the diagnostic criteria on prevalence and cardiovascular risk profiles of individuals with newly diagnosed diabetes in Japan: the Toranomon Hospital Health Management Center Study 2 (TOPICS 2). Diabetes Res Clin Pract 2012; 95: 283-290.
37. Inoue M, Inoue K, Akimoto K. Effects of age and sex in the diagnosis of type 2 diabetes using glycated haemoglobin in Japan: The Yuport medical checkup centre study. PLoS ONE 2012; 7: e40375.
38. Nakano M, Saitoh S, Takagi S, et al. Prevalence of glucose intolerance in Japan - From the National Survey on Circulatory Disorders in 1990. Jpn J Geriat. 1998; 35: 839-844.
39. Ministry of Health. Outline of the National Survey on Circulatory Disorders in 1990. J Health Welfare Stat 1993; 40: 36-59.
40. Ministry of Health. National Diabetes Survey, 1997. 1997; http://www.mhlw.go.jp/toukei/kouhyo/indexkk_4_1.html. Accessed 25 July, 2013.
41. Ministry of Health, Labour and Welfare. National Diabetes Survey, 2002. 2002; http://www.mhlw.go.jp/shingi/2004/03/s0318-15.html#tyosa. Accessed 25 July, 2012.
42. Ministry of Health, Labour and Welfare. National Health and Nutrition Survey, 2006. 2006; http://www.mhlw.go.jp/bunya/kenkou/eiyou08/01.html. Accessed 25 July, 2013.
43. Ministry of Health, Labour and Welfare. National Health and Nutrition Survey, 2007. 2007; http://www.mhlw.go.jp/bunya/kenkou/eiyou09/01.html. Accessed 25 July, 2012.
44. Ministry of Health, Labour and Welfare. National Health and Nutrition Survey, 2008. 2008; http://www.mhlw.go.jp/bunya/kenkou/eiyou/h20-houkoku.html. Accessed 25 July, 2013.
45. Ministry of Health, Labour and Welfare. National Health and Nutrition Survey, 2009. 2009; http://www.mhlw.go.jp/bunya/kenkou/eiyou/h21-houkoku.html. Accessed 25 July, 2013.
46. Ministry of Health, Labour and Welfare. National Health and Nutrition Survey, 2010. 2010; http://www.mhlw.go.jp/bunya/kenkou/eiyou/h22-houkoku.html. Accessed 25 July, 2013.
47. Uthman OA. Prevalence and pattern of HIV-related malnutrition among women in sub-Saharan Africa: a meta-analysis of demographic health surveys. BMC Public Health 2008; 8: 226.
48. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
49. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
50. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573.
51. National Statistics Center. Population distribution estimates (for 1990). 2013; http://www.e-stat.go.jp/SG1/estat/Xlsdl.do?sinfid=000000090263. Accessed 26 September, 2013.
52. National Statistics Center. Population distribution estimates (for 1995, 2000, 2005 and 2010). 2013; http://www.e-stat.go.jp/SG1/estat/Xlsdl.do?sinfid=000012976595. Accessed 26 September, 2013.
53. National Statistics Center. Population distribution projections. 2013; http://www.ipss.go.jp/syoushika/tohkei/newest04/s-kekka/1-9.xls. Accessed 26 September, 2013.
54. United Nations. World Population Prospects, 2012 revision. 2012; http://esa.un.org/unpd/wpp/unpp/panel_indicators.htm. Accessed 19 December, 2013.
55. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2012; http://www.R-project.org/. Accessed 25 July, 2013.
56. Gary TL, Brancati FL. Strategies to curb the epidemic of diabetes and obesity in primary care settings. J Gen Intern Med 2004; 19: 1242-1243.
57. Ministry of Health, Labour and Welfare. The second Health Japan 21 project. 2012; http://www.mhlw.go.jp/bunya/kenkou/dl/kenkounippon21_02.pdf. Accessed 25 July, 2013.
58. Sugawara A, Saito K, Sato M, et al. Thinness in Japanese young women. Epidemiology 2009; 20: 464-465.
59. Sasazuki S, Inoue M, Iwasaki M, et al. Combined impact of five lifestyle factors and subsequent risk of cancer: the Japan Public Health Center Study. Prev Med 2012; 54: 112-116.
60. Tamakoshi A, Tamakoshi K, Lin Y, et al. Healthy lifestyle and preventable death: findings from the Japan Collaborative Cohort (JACC) Study. Prev Med 2009; 48: 486-492.
61. Tada N, Maruyama C, Koba S, et al. Japanese dietary lifestyle and cardiovascular disease. J Atheroscler Thromb 2011; 18: 723-734.
62. Bonds DE, Lasser N, Qi L, et al. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 2006; 49: 459-468.